Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Servier
Servier
Turning Point Therapeutics, Inc.
AstraZeneca
Pfizer
Pfizer
Arvinas Inc.
Solve Therapeutics
Adela, Inc
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Degron Therapeutics Co.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.